Global Sickle Cell Market 2022 by Company, Regions, Type and Application, Forecast to 2028

  • receipt Report ID : 282553
  • calendar_today Published On: Mar, 2022
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

The Sickle Cell market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest study, due to COVID-19 pandemic, the global Sickle Cell market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospitals accounting for % of the Sickle Cell global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Diagnosis segment is altered to a % CAGR between 2022 and 2028.

Global key companies of Sickle Cell include Novartis, Bristol-Myers Squibb, Takeda, Bluebird Bio, and Global Blood Therapeutics, etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation

Sickle Cell market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Diagnosis

Treatment

Market segment by Application, can be divided into

Hospitals

Clinics

Ambulatory Surgical Centers

Market segment by players, this report covers

Novartis

Bristol-Myers Squibb

Takeda

Bluebird Bio

Global Blood Therapeutics

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:

Chapter 1, to describe Sickle Cell product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top players of Sickle Cell, with revenue, gross margin and global market share of Sickle Cell from 2019 to 2022.

Chapter 3, the Sickle Cell competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Sickle Cell market forecast, by regions, type and application, with revenue, from 2023 to 2028.

Chapter 11 and 12, to describe Sickle Cell research findings and conclusion, appendix and data source.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1 Market Overview

1.1 Product Overview and Scope of Sickle Cell

1.2 Classification of Sickle Cell by Type

1.2.1 Overview: Global Sickle Cell Market Size by Type: 2017 Versus 2021 Versus 2028

1.2.2 Global Sickle Cell Revenue Market Share by Type in 2021

1.2.3 Diagnosis

1.2.4 Treatment

1.3 Global Sickle Cell Market by Application

1.3.1 Overview: Global Sickle Cell Market Size by Application: 2017 Versus 2021 Versus 2028

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Ambulatory Surgical Centers

1.4 Global Sickle Cell Market Size & Forecast

1.5 Global Sickle Cell Market Size and Forecast by Region

1.5.1 Global Sickle Cell Market Size by Region: 2017 VS 2021 VS 2028

1.5.2 Global Sickle Cell Market Size by Region, (2017-2022)

1.5.3 North America Sickle Cell Market Size and Prospect (2017-2028)

1.5.4 Europe Sickle Cell Market Size and Prospect (2017-2028)

1.5.5 Asia-Pacific Sickle Cell Market Size and Prospect (2017-2028)

1.5.6 South America Sickle Cell Market Size and Prospect (2017-2028)

1.5.7 Middle East and Africa Sickle Cell Market Size and Prospect (2017-2028)

1.6 Market Drivers, Restraints and Trends

1.6.1 Sickle Cell Market Drivers

1.6.2 Sickle Cell Market Restraints

1.6.3 Sickle Cell Trends Analysis

2 Company Profiles

2 Company Profiles

2.1 Novartis

2.1.1 Novartis Details

2.1.2 Novartis Major Business

2.1.3 Novartis Sickle Cell Product and Solutions

2.1.4 Novartis Sickle Cell Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.1.5 Novartis Recent Developments and Future Plans

2.2 Bristol-Myers Squibb

2.2.1 Bristol-Myers Squibb Details

2.2.2 Bristol-Myers Squibb Major Business

2.2.3 Bristol-Myers Squibb Sickle Cell Product and Solutions

2.2.4 Bristol-Myers Squibb Sickle Cell Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.2.5 Bristol-Myers Squibb Recent Developments and Future Plans

2.3 Takeda

2.3.1 Takeda Details

2.3.2 Takeda Major Business

2.3.3 Takeda Sickle Cell Product and Solutions

2.3.4 Takeda Sickle Cell Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.3.5 Takeda Recent Developments and Future Plans

2.4 Bluebird Bio

2.4.1 Bluebird Bio Details

2.4.2 Bluebird Bio Major Business

2.4.3 Bluebird Bio Sickle Cell Product and Solutions

2.4.4 Bluebird Bio Sickle Cell Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.4.5 Bluebird Bio Recent Developments and Future Plans

2.5 Global Blood Therapeutics

2.5.1 Global Blood Therapeutics Details

2.5.2 Global Blood Therapeutics Major Business

2.5.3 Global Blood Therapeutics Sickle Cell Product and Solutions

2.5.4 Global Blood Therapeutics Sickle Cell Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.5.5 Global Blood Therapeutics Recent Developments and Future Plans

3 Market Competition, by Players

3 Market Competition, by Players

3.1 Global Sickle Cell Revenue and Share by Players (2019, 2020, 2021, and 2022)

3.2 Market Concentration Rate

3.2.1 Top 3 Sickle Cell Players Market Share in 2021

3.2.2 Top 10 Sickle Cell Players Market Share in 2021

3.2.3 Market Competition Trend

3.3 Sickle Cell Players Head Office, Products and Services Provided

3.4 Sickle Cell Mergers & Acquisitions

3.5 Sickle Cell New Entrants and Expansion Plans

4 Market Size Segment by Type

4 Market Size Segment by Type

4.1 Global Sickle Cell Revenue and Market Share by Type (2017-2022)

4.2 Global Sickle Cell Market Forecast by Type (2023-2028)

5 Market Size Segment by Application

5 Market Size Segment by Application

5.1 Global Sickle Cell Revenue Market Share by Application (2017-2022)

5.2 Global Sickle Cell Market Forecast by Application (2023-2028)

6 North America by Country, by Type, and by Application

6 North America by Country, by Type, and by Application

6.1 North America Sickle Cell Revenue by Type (2017-2028)

6.2 North America Sickle Cell Revenue by Application (2017-2028)

6.3 North America Sickle Cell Market Size by Country

6.3.1 North America Sickle Cell Revenue by Country (2017-2028)

6.3.2 United States Sickle Cell Market Size and Forecast (2017-2028)

6.3.3 Canada Sickle Cell Market Size and Forecast (2017-2028)

6.3.4 Mexico Sickle Cell Market Size and Forecast (2017-2028)

7 Europe by Country, by Type, and by Application

7 Europe by Country, by Type, and by Application

7.1 Europe Sickle Cell Revenue by Type (2017-2028)

7.2 Europe Sickle Cell Revenue by Application (2017-2028)

7.3 Europe Sickle Cell Market Size by Country

7.3.1 Europe Sickle Cell Revenue by Country (2017-2028)

7.3.2 Germany Sickle Cell Market Size and Forecast (2017-2028)

7.3.3 France Sickle Cell Market Size and Forecast (2017-2028)

7.3.4 United Kingdom Sickle Cell Market Size and Forecast (2017-2028)

7.3.5 Russia Sickle Cell Market Size and Forecast (2017-2028)

7.3.6 Italy Sickle Cell Market Size and Forecast (2017-2028)

8 Asia-Pacific by Region, by Type, and by Application

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Sickle Cell Revenue by Type (2017-2028)

8.2 Asia-Pacific Sickle Cell Revenue by Application (2017-2028)

8.3 Asia-Pacific Sickle Cell Market Size by Region

8.3.1 Asia-Pacific Sickle Cell Revenue by Region (2017-2028)

8.3.2 China Sickle Cell Market Size and Forecast (2017-2028)

8.3.3 Japan Sickle Cell Market Size and Forecast (2017-2028)

8.3.4 South Korea Sickle Cell Market Size and Forecast (2017-2028)

8.3.5 India Sickle Cell Market Size and Forecast (2017-2028)

8.3.6 Southeast Asia Sickle Cell Market Size and Forecast (2017-2028)

8.3.7 Australia Sickle Cell Market Size and Forecast (2017-2028)

9 South America by Country, by Type, and by Application

9 South America by Country, by Type, and by Application

9.1 South America Sickle Cell Revenue by Type (2017-2028)

9.2 South America Sickle Cell Revenue by Application (2017-2028)

9.3 South America Sickle Cell Market Size by Country

9.3.1 South America Sickle Cell Revenue by Country (2017-2028)

9.3.2 Brazil Sickle Cell Market Size and Forecast (2017-2028)

9.3.3 Argentina Sickle Cell Market Size and Forecast (2017-2028)

10 Middle East & Africa by Country, by Type, and by Application

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Sickle Cell Revenue by Type (2017-2028)

10.2 Middle East & Africa Sickle Cell Revenue by Application (2017-2028)

10.3 Middle East & Africa Sickle Cell Market Size by Country

10.3.1 Middle East & Africa Sickle Cell Revenue by Country (2017-2028)

10.3.2 Turkey Sickle Cell Market Size and Forecast (2017-2028)

10.3.3 Saudi Arabia Sickle Cell Market Size and Forecast (2017-2028)

10.3.4 UAE Sickle Cell Market Size and Forecast (2017-2028)

11 Research Findings and Conclusion

11 Research Findings and Conclusion

12 Appendix

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Sickle Cell Revenue by Type, (USD Million), 2017 VS 2021 VS 2028

Table 2. Global Sickle Cell Revenue by Application, (USD Million), 2017 VS 2021 VS 2028

Table 3. Global Market Sickle Cell Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)

Table 4. Global Sickle Cell Revenue (USD Million) by Region (2017-2022)

Table 5. Global Sickle Cell Revenue Market Share by Region (2023-2028)

Table 6. Novartis Corporate Information, Head Office, and Major Competitors

Table 7. Novartis Major Business

Table 8. Novartis Sickle Cell Product and Solutions

Table 9. Novartis Sickle Cell Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 10. Bristol-Myers Squibb Corporate Information, Head Office, and Major Competitors

Table 11. Bristol-Myers Squibb Major Business

Table 12. Bristol-Myers Squibb Sickle Cell Product and Solutions

Table 13. Bristol-Myers Squibb Sickle Cell Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 14. Takeda Corporate Information, Head Office, and Major Competitors

Table 15. Takeda Major Business

Table 16. Takeda Sickle Cell Product and Solutions

Table 17. Takeda Sickle Cell Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 18. Bluebird Bio Corporate Information, Head Office, and Major Competitors

Table 19. Bluebird Bio Major Business

Table 20. Bluebird Bio Sickle Cell Product and Solutions

Table 21. Bluebird Bio Sickle Cell Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 22. Global Blood Therapeutics Corporate Information, Head Office, and Major Competitors

Table 23. Global Blood Therapeutics Major Business

Table 24. Global Blood Therapeutics Sickle Cell Product and Solutions

Table 25. Global Blood Therapeutics Sickle Cell Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 26. Global Sickle Cell Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)

Table 27. Global Sickle Cell Revenue Share by Players (2019, 2020, 2021, and 2022)

Table 28. Breakdown of Sickle Cell by Company Type (Tier 1, Tier 2 and Tier 3)

Table 29. Sickle Cell Players Head Office, Products and Services Provided

Table 30. Sickle Cell Mergers & Acquisitions in the Past Five Years

Table 31. Sickle Cell New Entrants and Expansion Plans

Table 32. Global Sickle Cell Revenue (USD Million) by Type (2017-2022)

Table 33. Global Sickle Cell Revenue Share by Type (2017-2022)

Table 34. Global Sickle Cell Revenue Forecast by Type (2023-2028)

Table 35. Global Sickle Cell Revenue by Application (2017-2022)

Table 36. Global Sickle Cell Revenue Forecast by Application (2023-2028)

Table 37. North America Sickle Cell Revenue by Type (2017-2022) & (USD Million)

Table 38. North America Sickle Cell Revenue by Type (2023-2028) & (USD Million)

Table 39. North America Sickle Cell Revenue by Application (2017-2022) & (USD Million)

Table 40. North America Sickle Cell Revenue by Application (2023-2028) & (USD Million)

Table 41. North America Sickle Cell Revenue by Country (2017-2022) & (USD Million)

Table 42. North America Sickle Cell Revenue by Country (2023-2028) & (USD Million)

Table 43. Europe Sickle Cell Revenue by Type (2017-2022) & (USD Million)

Table 44. Europe Sickle Cell Revenue by Type (2023-2028) & (USD Million)

Table 45. Europe Sickle Cell Revenue by Application (2017-2022) & (USD Million)

Table 46. Europe Sickle Cell Revenue by Application (2023-2028) & (USD Million)

Table 47. Europe Sickle Cell Revenue by Country (2017-2022) & (USD Million)

Table 48. Europe Sickle Cell Revenue by Country (2023-2028) & (USD Million)

Table 49. Asia-Pacific Sickle Cell Revenue by Type (2017-2022) & (USD Million)

Table 50. Asia-Pacific Sickle Cell Revenue by Type (2023-2028) & (USD Million)

Table 51. Asia-Pacific Sickle Cell Revenue by Application (2017-2022) & (USD Million)

Table 52. Asia-Pacific Sickle Cell Revenue by Application (2023-2028) & (USD Million)

Table 53. Asia-Pacific Sickle Cell Revenue by Region (2017-2022) & (USD Million)

Table 54. Asia-Pacific Sickle Cell Revenue by Region (2023-2028) & (USD Million)

Table 55. South America Sickle Cell Revenue by Type (2017-2022) & (USD Million)

Table 56. South America Sickle Cell Revenue by Type (2023-2028) & (USD Million)

Table 57. South America Sickle Cell Revenue by Application (2017-2022) & (USD Million)

Table 58. South America Sickle Cell Revenue by Application (2023-2028) & (USD Million)

Table 59. South America Sickle Cell Revenue by Country (2017-2022) & (USD Million)

Table 60. South America Sickle Cell Revenue by Country (2023-2028) & (USD Million)

Table 61. Middle East & Africa Sickle Cell Revenue by Type (2017-2022) & (USD Million)

Table 62. Middle East & Africa Sickle Cell Revenue by Type (2023-2028) & (USD Million)

Table 63. Middle East & Africa Sickle Cell Revenue by Application (2017-2022) & (USD Million)

Table 64. Middle East & Africa Sickle Cell Revenue by Application (2023-2028) & (USD Million)

Table 65. Middle East & Africa Sickle Cell Revenue by Country (2017-2022) & (USD Million)

Table 66. Middle East & Africa Sickle Cell Revenue by Country (2023-2028) & (USD Million)

List of Figures

Figure 1. Sickle Cell Picture

Figure 2. Global Sickle Cell Revenue Market Share by Type in 2021

Figure 3. Diagnosis

Figure 4. Treatment

Figure 5. Sickle Cell Revenue Market Share by Application in 2021

Figure 6. Hospitals Picture

Figure 7. Clinics Picture

Figure 8. Ambulatory Surgical Centers Picture

Figure 9. Global Sickle Cell Market Size, (USD Million): 2017 VS 2021 VS 2028

Figure 10. Global Sickle Cell Revenue and Forecast (2017-2028) & (USD Million)

Figure 11. Global Sickle Cell Revenue Market Share by Region (2017-2028)

Figure 12. Global Sickle Cell Revenue Market Share by Region in 2021

Figure 13. North America Sickle Cell Revenue (USD Million) and Growth Rate (2017-2028)

Figure 14. Europe Sickle Cell Revenue (USD Million) and Growth Rate (2017-2028)

Figure 15. Asia-Pacific Sickle Cell Revenue (USD Million) and Growth Rate (2017-2028)

Figure 16. South America Sickle Cell Revenue (USD Million) and Growth Rate (2017-2028)

Figure 17. Middle East and Africa Sickle Cell Revenue (USD Million) and Growth Rate (2017-2028)

Figure 18. Sickle Cell Market Drivers

Figure 19. Sickle Cell Market Restraints

Figure 20. Sickle Cell Market Trends

Figure 21. Novartis Recent Developments and Future Plans

Figure 22. Bristol-Myers Squibb Recent Developments and Future Plans

Figure 23. Takeda Recent Developments and Future Plans

Figure 24. Bluebird Bio Recent Developments and Future Plans

Figure 25. Global Blood Therapeutics Recent Developments and Future Plans

Figure 26. Global Sickle Cell Revenue Share by Players in 2021

Figure 27. Sickle Cell Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021

Figure 28. Global Top 3 Players Sickle Cell Revenue Market Share in 2021

Figure 29. Global Top 10 Players Sickle Cell Revenue Market Share in 2021

Figure 30. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)

Figure 31. Global Sickle Cell Revenue Share by Type in 2021

Figure 32. Global Sickle Cell Market Share Forecast by Type (2023-2028)

Figure 33. Global Sickle Cell Revenue Share by Application in 2021

Figure 34. Global Sickle Cell Market Share Forecast by Application (2023-2028)

Figure 35. North America Sickle Cell Sales Market Share by Type (2017-2028)

Figure 36. North America Sickle Cell Sales Market Share by Application (2017-2028)

Figure 37. North America Sickle Cell Revenue Market Share by Country (2017-2028)

Figure 38. United States Sickle Cell Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 39. Canada Sickle Cell Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 40. Mexico Sickle Cell Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 41. Europe Sickle Cell Sales Market Share by Type (2017-2028)

Figure 42. Europe Sickle Cell Sales Market Share by Application (2017-2028)

Figure 43. Europe Sickle Cell Revenue Market Share by Country (2017-2028)

Figure 44. Germany Sickle Cell Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 45. France Sickle Cell Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 46. United Kingdom Sickle Cell Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 47. Russia Sickle Cell Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 48. Italy Sickle Cell Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 49. Asia-Pacific Sickle Cell Sales Market Share by Type (2017-2028)

Figure 50. Asia-Pacific Sickle Cell Sales Market Share by Application (2017-2028)

Figure 51. Asia-Pacific Sickle Cell Revenue Market Share by Region (2017-2028)

Figure 52. China Sickle Cell Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 53. Japan Sickle Cell Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 54. South Korea Sickle Cell Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 55. India Sickle Cell Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 56. Southeast Asia Sickle Cell Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 57. Australia Sickle Cell Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 58. South America Sickle Cell Sales Market Share by Type (2017-2028)

Figure 59. South America Sickle Cell Sales Market Share by Application (2017-2028)

Figure 60. South America Sickle Cell Revenue Market Share by Country (2017-2028)

Figure 61. Brazil Sickle Cell Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 62. Argentina Sickle Cell Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 63. Middle East and Africa Sickle Cell Sales Market Share by Type (2017-2028)

Figure 64. Middle East and Africa Sickle Cell Sales Market Share by Application (2017-2028)

Figure 65. Middle East and Africa Sickle Cell Revenue Market Share by Country (2017-2028)

Figure 66. Turkey Sickle Cell Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 67. Saudi Arabia Sickle Cell Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 68. UAE Sickle Cell Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 69. Methodology

Figure 70. Research Process and Data Source

shopping_cart License Type

Buy Now

email Quick Contact

tag_faces Our Clients

help Need Help?

Please contact directly on our US and India numbers

+1-201-465-4211

Please feel free to write an email to us or to use our electronic ticketing system.

sales@marketsandresearch.biz